{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:09:28Z","timestamp":1779469768673,"version":"3.53.1"},"reference-count":0,"publisher":"Clinical Care Targeted Communications Group, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.37765\/ajmc.2026.89933","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:32:49Z","timestamp":1779467569000},"page":"257","source":"Crossref","is-referenced-by-count":0,"title":["Toward Equitable Access to Cell and Gene Therapies: Rethinking Co-Payments"],"prefix":"10.37765","volume":"32","member":"24492","published-online":{"date-parts":[[2026,4,16]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:32:49Z","timestamp":1779467569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/toward-equitable-access-to-cell-and-gene-therapies-rethinking-co-payments"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,1]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2026.89933","relation":{},"ISSN":["1088-0224","1936-2692"],"issn-type":[{"value":"1088-0224","type":"print"},{"value":"1936-2692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}